BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24886118)

  • 1. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing.
    Strom SP; Lozano R; Lee H; Dorrani N; Mann J; O'Lague PF; Mans N; Deignan JL; Vilain E; Nelson SF; Grody WW; Quintero-Rivera F
    BMC Med Genet; 2014 May; 15():49. PubMed ID: 24886118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo Mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome.
    Dunkerton S; Field M; Cho V; Bertram E; Whittle B; Groves A; Goel H
    Am J Med Genet A; 2015 Sep; 167A(9):2182-7. PubMed ID: 25929198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The progression of Wiedemann-Steiner syndrome in adulthood and two novel variants in the KMT2A gene.
    Feldman HR; Dlouhy SR; Lah MD; Payne KK; Weaver DD
    Am J Med Genet A; 2019 Feb; 179(2):300-305. PubMed ID: 30549396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wiedemann-Steiner syndrome in two patients from Portugal.
    Grangeia A; Leão M; Moura CP
    Am J Med Genet A; 2020 Jan; 182(1):25-28. PubMed ID: 31710778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wiedemann-Steiner Syndrome With 2 Novel KMT2A Mutations.
    Min Ko J; Cho JS; Yoo Y; Seo J; Choi M; Chae JH; Lee HR; Cho TJ
    J Child Neurol; 2017 Feb; 32(2):237-242. PubMed ID: 27777327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel de novo mutation (p.Pro1310Glnfs*46) in KMT2A caused Wiedemann-Steiner Syndrome in a Chinese boy with postnatal growth retardation: a case report.
    Chen M; Liu R; Wu C; Li X; Wang Y
    Mol Biol Rep; 2019 Oct; 46(5):5555-5559. PubMed ID: 31250358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiedemann-Steiner syndrome with a novel pathogenic variant in KMT2A: a case report.
    Ramirez-Montaño D; Pachajoa H
    Colomb Med (Cali); 2019 Mar; 50(1):40-45. PubMed ID: 31168168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wiedemann-Steiner syndrome: Novel pathogenic variant and review of literature.
    Aggarwal A; Rodriguez-Buritica DF; Northrup H
    Eur J Med Genet; 2017 Jun; 60(6):285-288. PubMed ID: 28359930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations.
    Miyake N; Tsurusaki Y; Koshimizu E; Okamoto N; Kosho T; Brown NJ; Tan TY; Yap PJ; Suzumura H; Tanaka T; Nagai T; Nakashima M; Saitsu H; Niikawa N; Matsumoto N
    Clin Genet; 2016 Jan; 89(1):115-9. PubMed ID: 25810209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital immunodeficiency in an individual with Wiedemann-Steiner syndrome due to a novel missense mutation in KMT2A.
    Stellacci E; Onesimo R; Bruselles A; Pizzi S; Battaglia D; Leoni C; Zampino G; Tartaglia M
    Am J Med Genet A; 2016 Sep; 170(9):2389-93. PubMed ID: 27320412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: A study of 33 French cases.
    Baer S; Afenjar A; Smol T; Piton A; Gérard B; Alembik Y; Bienvenu T; Boursier G; Boute O; Colson C; Cordier MP; Cormier-Daire V; Delobel B; Doco-Fenzy M; Duban-Bedu B; Fradin M; Geneviève D; Goldenberg A; Grelet M; Haye D; Heron D; Isidor B; Keren B; Lacombe D; Lèbre AS; Lesca G; Masurel A; Mathieu-Dramard M; Nava C; Pasquier L; Petit A; Philip N; Piard J; Rondeau S; Saugier-Veber P; Sukno S; Thevenon J; Van-Gils J; Vincent-Delorme C; Willems M; Schaefer E; Morin G
    Clin Genet; 2018 Jul; 94(1):141-152. PubMed ID: 29574747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further delineation of the phenotype of truncating KMT2A mutations: The extended Wiedemann-Steiner syndrome.
    Sun Y; Hu G; Liu H; Zhang X; Huang Z; Yan H; Wang L; Fan Y; Gu X; Yu Y
    Am J Med Genet A; 2017 Feb; 173(2):510-514. PubMed ID: 27759909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A (MLL).
    Mendelsohn BA; Pronold M; Long R; Smaoui N; Slavotinek AM
    Am J Med Genet A; 2014 Aug; 164A(8):2079-83. PubMed ID: 24818805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo mutations in MLL cause Wiedemann-Steiner syndrome.
    Jones WD; Dafou D; McEntagart M; Woollard WJ; Elmslie FV; Holder-Espinasse M; Irving M; Saggar AK; Smithson S; Trembath RC; Deshpande C; Simpson MA
    Am J Hum Genet; 2012 Aug; 91(2):358-64. PubMed ID: 22795537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous loss-of-function variants of TASP1, a gene encoding an activator of the histone methyltransferases KMT2A and KMT2D, cause a syndrome of developmental delay, happy demeanor, distinctive facial features, and congenital anomalies.
    Suleiman J; Riedhammer KM; Jicinsky T; Mundt M; Werner L; Gusic M; Burgemeister AL; Alsaif HS; Abdulrahim M; Moghrabi NN; Nicolas-Jilwan M; AlSayed M; Bi W; Sampath S; Alkuraya FS; El-Hattab AW
    Hum Mutat; 2019 Nov; 40(11):1985-1992. PubMed ID: 31209944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA Sequencing and Pathway Analysis Identify Important Pathways Involved in Hypertrichosis and Intellectual Disability in Patients with Wiedemann-Steiner Syndrome.
    Mietton L; Lebrun N; Giurgea I; Goldenberg A; Saintpierre B; Hamroune J; Afenjar A; Billuart P; Bienvenu T
    Neuromolecular Med; 2018 Sep; 20(3):409-417. PubMed ID: 30014449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients.
    Li N; Wang Y; Yang Y; Wang P; Huang H; Xiong S; Sun L; Cheng M; Song C; Cheng X; Ding Y; Chang G; Chen Y; Xu Y; Yu T; Yao RE; Shen Y; Wang X; Wang J
    Orphanet J Rare Dis; 2018 Oct; 13(1):178. PubMed ID: 30305169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome.
    Lebrun N; Giurgea I; Goldenberg A; Dieux A; Afenjar A; Ghoumid J; Diebold B; Mietton L; Briand-Suleau A; Billuart P; Bienvenu T
    Eur J Hum Genet; 2018 Jan; 26(1):107-116. PubMed ID: 29203834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel deletion mutation in KMT2A identified in a child with ID/DD and blood eosinophilia.
    Zhang H; Xiang B; Chen H; Chen X; Cai T
    BMC Med Genet; 2019 Mar; 20(1):38. PubMed ID: 30841869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.